Cargando…

EMT and Stemness—Key Players in Pancreatic Cancer Stem Cells

Metastasis and tumor progression are the major cause of death in patients suffering from pancreatic ductal adenocarcinoma. Tumor growth and especially dissemination are typically associated with activation of an epithelial-to-mesenchymal transition (EMT) program. This phenotypic transition from an e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rodriguez-Aznar, Eva, Wiesmüller, Lisa, Sainz, Bruno, Hermann, Patrick C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721598/ https://www.ncbi.nlm.nih.gov/pubmed/31398893 http://dx.doi.org/10.3390/cancers11081136

Ejemplares similares

Circulating Tumor Cells in Breast Cancer Patients: A Balancing Act between Stemness, EMT Features and DNA Damage Responses
por: Heitmeir, Benedikt, et al.
Publicado: (2022)

Mesenchymal stem cells: key players in cancer progression
por: Ridge, Sarah M., et al.
Publicado: (2017)

Cancer Stem Cells—Key Players in Tumor Relapse
por: Marzagalli, Monica, et al.
Publicado: (2021)

Cancer Stem Cells, EMT, and Developmental Pathway Activation in Pancreatic Tumors
por: Hindriksen, Sanne, et al.
Publicado: (2012)

MEK Inhibition Targets Cancer Stem Cells and Impedes Migration of Pancreatic Cancer Cells In Vitro and In Vivo
por: Walter, Karolin, et al.
Publicado: (2019)

The Cancer Stem Cell in Hepatocellular Carcinoma
por: Schulte, Lucas-Alexander, et al.
Publicado: (2020)

Telomerase and Pluripotency Factors Jointly Regulate Stemness in Pancreatic Cancer Stem Cells
por: Walter, Karolin, et al.
Publicado: (2021)

The Ever-Evolving Concept of the Cancer Stem Cell in Pancreatic Cancer
por: Valle, Sandra, et al.
Publicado: (2018)

The CXCL12 Crossroads in Cancer Stem Cells and Their Niche
por: López-Gil, Juan Carlos, et al.
Publicado: (2021)

The epithelial to mesenchymal transition (EMT) and cancer stem cells: implication for treatment resistance in pancreatic cancer
por: Zhou, Pingting, et al.
Publicado: (2017)

Cancer Stem Cells, Bone and Tumor Microenvironment: Key Players in Bone Metastases
por: Roato, Ilaria, et al.
Publicado: (2018)

The Anthrax Toxin Receptor 1 (ANTXR1) Is Enriched in Pancreatic Cancer Stem Cells Derived from Primary Tumor Cultures
por: Alcalá, Sonia, et al.
Publicado: (2019)

Exploiting oxidative phosphorylation to promote the stem and immunoevasive properties of pancreatic cancer stem cells
por: Valle, Sandra, et al.
Publicado: (2020)

Cancer Stem Cells: Emerging Key Players in Immune Evasion of Cancers
por: Lei, Martina Mang Leng, et al.
Publicado: (2021)

Proteoglycans Determine the Dynamic Landscape of EMT and Cancer Cell Stemness
por: Karagiorgou, Zoi, et al.
Publicado: (2022)

On the connections between cancer stem cells and EMT
por: Cioce, Mario, et al.
Publicado: (2012)

A new insight for stem cell therapy: apoptotic stem cells as a key player
por: Huang, Yuhe, et al.
Publicado: (2022)

Tackling Cancer Stem Cells via Inhibition of EMT Transcription Factors
por: Mladinich, Megan, et al.
Publicado: (2016)

Wnt Signaling in Ovarian Cancer Stemness, EMT, and Therapy Resistance
por: Teeuwssen, Miriam, et al.
Publicado: (2019)

New Insights into the Crossroads between EMT and Stemness in the Context of Cancer
por: Fabregat, Isabel, et al.
Publicado: (2016)

Betulinic acid inhibits stemness and EMT of pancreatic cancer cells via activation of AMPK signaling
por: Sun, Liankang, et al.
Publicado: (2018)

Up‐regulation of glycolysis promotes the stemness and EMT phenotypes in gemcitabine‐resistant pancreatic cancer cells
por: Zhao, Hengqiang, et al.
Publicado: (2017)

Glutathione metabolism is essential for self-renewal and chemoresistance of pancreatic cancer stem cells
por: Jagust, Petra, et al.
Publicado: (2020)

ISG15 and ISGylation is required for pancreatic cancer stem cell mitophagy and metabolic plasticity
por: Alcalá, Sonia, et al.
Publicado: (2020)

Targeting SRC Kinase Signaling in Pancreatic Cancer Stem Cells
por: Alcalá, Sonia, et al.
Publicado: (2020)

Cancer Stem Cells and Epithelial-to-Mesenchymal Transition (EMT)-Phenotypic Cells: Are They Cousins or Twins?
por: Kong, Dejuan, et al.
Publicado: (2011)

EMT and Treatment Resistance in Pancreatic Cancer
por: Gaianigo, Nicola, et al.
Publicado: (2017)

Stem Cells and Neuroprotection: Understanding the Players
por: Pearce, Virginia
Publicado: (2010)

Potential Role of MSC/Cancer Cell Fusion and EMT for Breast Cancer Stem Cell Formation
por: Hass, Ralf, et al.
Publicado: (2019)

Dynamics of Phenotypic Heterogeneity Associated with EMT and Stemness during Cancer Progression
por: Jolly, Mohit Kumar, et al.
Publicado: (2019)

EMT‐associated microRNAs and their roles in cancer stemness and drug resistance
por: Pan, Guangtao, et al.
Publicado: (2021)

EMT Involved in Migration of Stem/Progenitor Cells for Pituitary Development and Regeneration
por: Yoshida, Saishu, et al.
Publicado: (2016)

Cancer Stem Cells in Pancreatic Cancer
por: Bao, Qi, et al.
Publicado: (2010)

Interplay of Stem Cell Characteristics, EMT, and Microtentacles in Circulating Breast Tumor Cells
por: Charpentier, Monica, et al.
Publicado: (2013)

The nutritional phenome of EMT-induced cancer stem-like cells
por: Cuyàs, Elisabet, et al.
Publicado: (2014)

Multimodal Treatment Eliminates Cancer Stem Cells and Leads to Long-Term Survival in Primary Human Pancreatic Cancer Tissue Xenografts
por: Hermann, Patrick C., et al.
Publicado: (2013)

Cancer Stem Cells Are Possible Key Players in Regulating Anti-Tumor Immune Responses: The Role of Immunomodulating Molecules and MicroRNAs
por: Tomei, Sara, et al.
Publicado: (2021)

EMT and stemness: flexible processes tuned by alternative splicing in development and cancer progression
por: Pradella, Davide, et al.
Publicado: (2017)

Targeting FTO Suppresses Pancreatic Carcinogenesis via Regulating Stem Cell Maintenance and EMT Pathway
por: Garg, Rachana, et al.
Publicado: (2022)

NANOGP8 is the key regulator of stemness, EMT, Wnt pathway, chemoresistance, and other malignant phenotypes in gastric cancer cells
por: Ma, Xia, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_im7pirl5dsm05hrap492dbei9j